References
- Alker D., Beresford A. P., Kobylecki R., Macrae P. V. Biotransformation of amlodipine: Identification and synthesis of the metabolites found in rat, dog and man. Arzneittel Forschung 1988, submitted for publication
- Arrowsmith J. E., Campbell S. F., Cross P. E., Stubbs J. K., Burges R. A., Gardiner D. G., Blackburn K. J. Long-acting dihydropyridine calcium antagonists. 1,2-alkoxymethyl derivatives incorporating basic substituents. Journal of Medicinal Chemistry 1986; 29: 1696–1702
- Baarnhielm C., Skanberg I., Borg K. O. Cytochrome P-450-dependent oxidation of felodipine—a 1,4-dihydropyridine—to the corresponding pyridine. Xenobiotica 1984; 14: 719–726
- Baez M. A., Weidler D. J. Antihypertensive effect of amlodipine in hypertensive patients. Journal of Hypertension 1986; 4(suppl 5)458–460
- Beresford A. P., Macrae P. V., Stopher D. A., Wood B. A. Analysis of amlodipine in human plasma by gas chromatography. Journal of Chromatography 1987b; 420: 178–183
- Beresford A. P., Macrae P. V., Stopher D. A. Metabolism of amlodipine in rat and dog. Xenobiotica 1988; 18, (in the press)
- Burges R. A., Gardiner D. G., Gwilt M., Higgins A. J., Blackburn K. J., Campbell S. F., Cross P. E., Stubbs J. K. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors. Journal of Cardiovascular Pharmacology 1986; 9: 110–119
- Edgar B., Regardh C. G., Johnsson G., Johansson L., Lundborg P., Lofberg I., Ronn O. Felodipine kinetics in healthy man. Clinical Pharmacology and Therapeutics 1985; 38: 205–211
- Faulkner J. K., McGibney D., Chasseaud L. F., Perry J. C., Taylor I. W. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. British Journal of Clinical Pharmacology 1986; 22: 21–25
- Graham D. J. M., Dow R. J., Freedman D., Mroszczak E., Ling T. Pharmacokinetics of nicardipine following oral and intravenous administration in man. Postgraduate Medical Journal 1984; 60(Suppl. 4)7–10
- Kondo S., Kuchiki A., Yamamoto K., Akimoto K., Takahashi K., Awata N., Sugimoto I. Identification of nifedipine metabolites and determination by gas chromatography. Chemical Pharmacology Bulletin 1980; 28: 1–7
- Medanwald H., Schlossman K., Wunsche C. Structural determination of the renal excretion products of 4-(2-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethosy-1,4-dihydropyridine. Arzneittel Forschung 1972; 35: 668
- Midgley I., Chasseaud L. F., Taylor I. W., Walmsley L. M., Fowkes A. G. Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in man. Xenobiotica 1985; 15: 965–977
- Rush W. R., Alexander O., Hall D. J., Cairncross L., Dow R. J., Graham D. J. The metabolism of nicardipine hydrochloride in healthy male volunteers. Xenobiotica 1986; 16: 341–349
- Sugimoto I., Kuchiki A., Nakagawa H., Tohgo K., Kondo S., Iwane I., Takahashi K. Dissolution and absorption of nifedipine from nifedipine—polyvinylpyrrolidone coprecipitate. Drug Development and Industrial Pharmacy 1980; 6: 137–160
- Walkenstein S. S., Intoccia A. P., Flanagan T. C., Hwang B., Flint D., Weinstock J., Villaris A. J., Blackburn D., Green H. Metabolism of the antihypertensive agent 1,4-dihydro-2,6-dimethyl-4-(2,trifluoromethylphenyl)-3–5-pyridine-carboxylic acid diethyl ester. Journal of Pharmacological Science 1973; 62: 580–584
- Waller D. G., Renwick A. G., Gruchy B. S., George C. F. The first pass metabolism of nifedipine in man. British Journal of Clinical Pharmacology 1984; 18: 931–954